Second-trimester Down syndrome maternal serum marker screening: A prospective study of 11 040 twin pregnancies

Prenatal Diagnosis

Volumn 28, Issue 12, 2008, Pages 1105-1109

  Garchet Beaudron, Aurélie ^a   Dreux, Sophie ^a   Leporrier, Nathalie ^b   Oury, Jean François ^a   Muller, Françoise ^a,c   Lemay, C ^d   Bourdrel, J M ^d   Gras, V ^d   Roudon, T ^d   Real J Y ^d   Dumas, P ^d   Ruedas, E ^d   Souby, J ^d   Andlauer, P ^d   Gaeremynck, E ^d   Duchene B ^d   Barba, F ^d   Pomel, C ^d   Dingeon, B ^d   Doche, C ^d   Peraud, I ^d   Chahine, H ^d   Finot, C ^d   Ramaorasy, M H ^d   Lallaoui, H ^d   Clement P ^d   Lohman, L ^d   Mintz, M ^d   Berreville, E ^d   Sigogneau, P ^d   Duprey, F ^d   Couplet, G ^d   Mainardi, A ^d   Chianea T ^d   Veyrat, B ^d   Piedimonte, A ^d   Sault, C ^d   Roux, F ^d   Boulbina, A ^d   Giorgetti, Caparros ^d   Sainte Rose, M ^d   Larcher, M E ^d   Wasel, M ^d   Michotey, O ^d   Baret, A ^d   Mirallie S ^d   Delpech, ^d   Cabrol, M ^d   Got, L ^d   Choblet, E ^d   Barguil, Y ^d   Czerkiewicz, I ^d   Dreux, S ^d   Muller, F ^d   Khalfon, D ^d   Cassuto, G ^d   Brethome, B ^d   Panneciere M T ^e   Palleau, S ^e   Aidenbaum, J C ^d   Hamberger, C ^f   Druart, L ^f   Bernard, M ^g   Brochet, C ^g   Millet, C ^d   Bounaud, M P ^d   Guiardiola, P ^d   Antoine, P ^d   Belot, G ^d   Chamson, A ^d   Mulot, H ^d   Roy, C ^d   Fortenfant, F ^h   Blancher, A ^h   Dudragne, D ^d   Cara, B ^d   Duchateau, P ^d   Odaert, H ^d   Angotti Jalladeau, ^d   Touboul, C ⁱ   Le Fiblec, B ^j   Fontpre C H ^d   Frances, A M ^d   Luton, D ^k   Mahieu Caputo, D ^l   Uzan, M ^m   Dumez, Y ⁿ   Carbone, B ^o   Lewin, F ^p   Uzan, S ^q   Jouannic, J M ^r   more..

^a HÔPITAL ROBERT DEBRÉ   (France)

^b CHU CÔTE DE NACRE   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d Hôpital Robert Debré ^*

^e AMERICAN HOSPITAL OF PARIS   (France)

^f LCL Paris Laboratory   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h TOULOUSE UNIVERSITY HOSPITAL   (France)

ⁱ CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^j CH   (France)

^k Section of Radiology   (France)

^l BICHAT HOSPITAL   (France)

^m HÔPITAL JEAN VERDIER   (France)

ⁿ HÔPITAL NECKER ENFANTS MALADES   (France)

^o HÔPITAL SAINT ANTOINE   (France)

^p HÔPITAL SAINT VINCENT DE PAUL   (France)

^q HÔPITAL TENON   (France)

^r ARMAND TROUSSEAU HOSPITAL   (France)

more..

Author keywords

Multiple pregnancy; Prenatal screening; Trisomy 21

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DOWN SYNDROME; FALSE POSITIVE RESULT; FEMALE; FETUS; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SERUM; MULTIPLE PREGNANCY; PRENATAL SCREENING; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; TRISOMY 21; TWIN PREGNANCY;

EID: 57149109377     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2145     Document Type: Article

References (19)

1. Chasen ST, Perni SC, Kalish RB, Chervenak FA. 2007. First-trimester risk assessment for trisomies 21 and 18 in twin pregnancy. Am J Obstet Gynecol 197: 374a1-374a3.
2. Cuckle HS. 1998. Down's syndrome screening in twins. J Med Screen 5: 3-4.
3. Cuckle HS. 2000. Biochemical screening for Down syndrome. Eur J Obstet Gynecol Reprod Biol 92: 97-102.
4. Doyle PE, Beral V, Botting B, Wale CJ. 1991. Congenital malformations in twins in England and Wales. J Epidemiol Community Health 45: 43-48.
5. Malone FD, Canick JA, Ball RH, et al. 2005. First trimester or second trimester screening, of both, for Down syndrome. N Engl J Med 353: 2001-2011.
6. Meyers C, Rony A, Dungan J, Prenger V. 1997. Aneuploidy in twin gestations: When is maternal age advanced? Obstet Gynecol 89: 248-251.
7. Morris JK, Mutton DE, Alberman E. 2002. Revised estimates of maternal age specific live birth prevalence of Down syndrome. J Med Screen 9: 2-6.
8. Muller F, Benattar C, Audibert F, Roussel N, Dreux S, Cuckle H. 2003a. First-trimester screening for Down syndrome in France combining fetal nuchal translucency measurement and biochemical markers. Prenat Diagn 23: 833-836.
9. Muller F, Dreux S, Dupoizat H, et al. 2003b. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity. Prenat Diagn 23: 331-335.
10. Muller F, Forestier F, Dingeon B, ABA Study Group. 2002. Second-trimester trisomy 21 maternal serum marker screening. Results of a countrywide study of 854 902 patients. Prenat Diagn 6: 925-929.
11. Nicolaides KH, Spencer K, Avjidou K, Faiola S, Falcon O. 2005. Multicenter Study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated-two stages first trimester screening. Ultrasound Obstet Gynecol 25: 221-226.
12. Pandya PP, Hilbert F, Snijders RJ, Nicolaides KH. 1995. Nuchal translucency thickness and crow-rump length in twin pregnancies with chromosomally abnormal fetuses. J Ultrasound Med 14: 565-568.
13. Sebire NJ, Snijders RJ, Hughes K, Sepulveda W, Nicolaides KH. 1996. Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Br J Obstet Gynaecol 103: 999-1003.
14. Spencer K. 2000. Screening for trisomy 21 in twins pregnancies in the first trimester using free β-hCG and PAPP-A combined with fetal nuchal translucency thickness. Prenat Diagn 20: 91-95.
15. Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH. 2003. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: A review of three years prospective experience. BJOG 110: 281-286.
16. Tandberg A, Bjorge T, Bordahl PE, Skjaerven R. 2007. Increasing twinning rates in Norway 1967-2004: the influence of maternal age and assisted reproductive technology (ART). Acta Obstet Gynecol Scand 86: 833-839.
17. Wald NJ, Rish S. 2005. Prenatal screening for Down syndrome and neural tube defects in twin pregnancies. Prenat Diagn 25: 740-745.
18. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. 2003. First-and second trimester antenatal screening for Down's syndrome: the results of the serum, urine and ultrasound screening study (SURUSS). J Med Screen 10: 56-104.
19. Yukobowich E, Anteby EY, Cohen SM, Lavy Y, Granat M, Yagel S. 2001. Risk of fetal loss in twin pregnancies undergoing second trimester amniocentesis. Obstet Gynecol 98: 231-234.